These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9000780)

  • 21. The effect of nortriptyline in elderly patients with cardiac conduction disease.
    Dietch JT; Fine M
    J Clin Psychiatry; 1990 Feb; 51(2):65-7. PubMed ID: 2298706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychotropic drug therapy in children].
    Eggers C
    Fortschr Med; 1977 Sep; 95(33):2028-33. PubMed ID: 334649
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acrocyanosis as a side effect of tricyclic antidepressants: a case report.
    Karakaya I; Aydoğan M; Coşkun A; Gökalp AS
    Turk J Pediatr; 2003; 45(2):155-7. PubMed ID: 12921305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
    Szobot CM; Rohde LA; Bukstein O; Molina BS; Martins C; Ruaro P; Pechansky F
    Addiction; 2007 Jul; 102(7):1122-30. PubMed ID: 17567400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stimulants.
    Wilens TE; Biederman J
    Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nortriptyline Abuse: A Case Report and Review of the Literature.
    Miller JJ; Whiting WL; Catalano G; Sanchez DL
    Clin Neuropharmacol; 2019; 42(3):108-110. PubMed ID: 30920402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exacerbation of psychosis by tricyclic antidepressants in delusional depression.
    Nelson JC; Bowers MB; Sweeney DR
    Am J Psychiatry; 1979 Apr; 136(4B):574-6. PubMed ID: 426146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric cannabinoid hyperemesis: two cases.
    Miller JB; Walsh M; Patel PA; Rogan M; Arnold C; Maloney M; Donnino M
    Pediatr Emerg Care; 2010 Dec; 26(12):919-20. PubMed ID: 21131803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM; Caliendo GC
    Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention deficit disorder during adolescence: a review.
    Faigel HC; Sznajderman S; Tishby O; Turel M; Pinus U
    J Adolesc Health; 1995 Mar; 16(3):174-84. PubMed ID: 7779826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 39. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE; Pratt HD; Patel DR
    Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
    van der Gaag RJ; Buitelaar JK
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1261-6. PubMed ID: 1861762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.